BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23313350)

  • 1. Elevated rates of force development and MgATP binding in F764L and S532P myosin mutations causing dilated cardiomyopathy.
    Palmer BM; Schmitt JP; Seidman CE; Seidman JG; Wang Y; Bell SP; Lewinter MM; Maughan DW
    J Mol Cell Cardiol; 2013 Apr; 57():23-31. PubMed ID: 23313350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac myosin isoforms exhibit differential rates of MgADP release and MgATP binding detected by myocardial viscoelasticity.
    Wang Y; Tanner BC; Lombardo AT; Tremble SM; Maughan DW; Vanburen P; Lewinter MM; Robbins J; Palmer BM
    J Mol Cell Cardiol; 2013 Jan; 54():1-8. PubMed ID: 23123290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.
    Tang W; Unrath WC; Desetty R; Yengo CM
    J Biol Chem; 2019 Nov; 294(46):17314-17325. PubMed ID: 31578282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
    Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function.
    Schmitt JP; Debold EP; Ahmad F; Armstrong A; Frederico A; Conner DA; Mende U; Lohse MJ; Warshaw D; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14525-30. PubMed ID: 16983074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin dilated cardiomyopathy mutation S532P disrupts actomyosin interactions, leading to altered muscle kinetics, reduced locomotion, and cardiac dilation in
    Trujillo AS; Hsu KH; Puthawala J; Viswanathan MC; Loya A; Irving TC; Cammarato A; Swank DM; Bernstein SI
    Mol Biol Cell; 2021 Aug; 32(18):1690-1706. PubMed ID: 34081531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
    Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
    FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.
    Ujfalusi Z; Vera CD; Mijailovich SM; Svicevic M; Yu EC; Kawana M; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2018 Jun; 293(23):9017-9029. PubMed ID: 29666183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay Between the Effects of Dilated Cardiomyopathy Mutation (R206L) and the Protein Kinase C Phosphomimic (T204E) of Rat Cardiac Troponin T Are Differently Modulated by α- and β-Myosin Heavy Chain Isoforms.
    Michael JJ; Chandra M
    J Am Heart Assoc; 2016 Mar; 5(3):e002777. PubMed ID: 27001966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified
    Yuan CC; Kazmierczak K; Liang J; Zhou Z; Yadav S; Gomes AV; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2338-E2347. PubMed ID: 29463717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
    Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
    Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms.
    Gollapudi SK; Tardiff JC; Chandra M
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H884-93. PubMed ID: 25681424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin MgADP release rate decreases at longer sarcomere length to prolong myosin attachment time in skinned rat myocardium.
    Tanner BC; Breithaupt JJ; Awinda PO
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2087-97. PubMed ID: 26475586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tail length and E525K dilated cardiomyopathy mutant alter human β-cardiac myosin super-relaxed state.
    Duno-Miranda S; Nelson SR; Rasicci DV; Bodt SML; Cirilo JA; Vang D; Sivaramakrishnan S; Yengo CM; Warshaw DM
    J Gen Physiol; 2024 Jun; 156(6):. PubMed ID: 38709176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.
    Klos M; Mundada L; Banerjee I; Morgenstern S; Myers S; Leone M; Kleid M; Herron T; Devaney E
    Arch Biochem Biophys; 2017 Feb; 615():53-60. PubMed ID: 28088328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cardiac myosin light chain kinase gene mutation on development of dilated cardiomyopathy.
    Hodatsu A; Fujino N; Uyama Y; Tsukamoto O; Imai-Okazaki A; Yamazaki S; Seguchi O; Konno T; Hayashi K; Kawashiri MA; Asano Y; Kitakaze M; Takashima S; Yamagishi M
    ESC Heart Fail; 2019 Apr; 6(2):406-415. PubMed ID: 30690923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.